MedTrace Logo

Implementation of the Fatty Liver Index in Primary Care

NCT06363617 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 434

Last updated 2025-06-29

No results posted yet for this study

Summary

This trial aims to evaluate the impact on cardiovascular risk control in individuals in risk of being affected by hepatic steatosis through the implementation of a screening test (Fatty Liver Index) in Primary Care. Medical teams in a primary care center will be divided into 2 groups, with one group using the screening test in their clinical practice. The number of interventions on cardiovascular risk occurring in patients attended by each group of medical teams will be evaluated and compared.

Conditions

  • Hepatic Steatosis
  • Overweight and Obesity

Interventions

OTHER

FLI

Health professionals will use the FLI test in their clinical practice

Sponsors & Collaborators

  • Consorci Sanitari de l'Alt Penedès i Garraf

    lead OTHER

Principal Investigators

  • M Carmen Rosas, MD · CSAPG

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-02
Primary Completion
2025-02-01
Completion
2025-02-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06363617 on ClinicalTrials.gov